Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

º¹ÅëÀÌ ÀÖ´Â ¼Ò¾Æû¼Ò³â¿¡¼­ ½Äµµ¿°ÀÇÀ¯º´·ü°ú À§ÇèÀÎÀÚ Prevalence and Risk Factors Associated with Esophagitisin Children with Abdominal Pain

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2008³â 11±Ç 2È£ p.103 ~ 109
±ÇÇöÁ¤, Á¶°­È£, ¼Õµ¿¿ì, Â÷ÇÑ, ·ùÀÏ, ÀÌ´ë¿ë,
¼Ò¼Ó »ó¼¼Á¤º¸
±ÇÇöÁ¤ ( Kwon Hyun-Jung ) 
°¡ÃµÀÇ°úÇдëÇб³ ¼Ò¾Æ°úÇб³½Ç

Á¶°­È£ ( Cho Kang-Ho ) 
°¡ÃµÀÇ°úÇдëÇб³ ±æº´¿ø ¼Ò¾Æ°ú
¼Õµ¿¿ì ( Son Dong-Woo ) 
°¡ÃµÀÇ°úÇдëÇб³ ±æº´¿ø ¼Ò¾Æ°ú
Â÷ÇÑ ( Tchah Hann ) 
°¡ÃµÀÇ°úÇдëÇб³ ±æº´¿ø ¼Ò¾Æ°ú
·ùÀÏ ( Ryoo Eell ) 
°¡ÃµÀÇ°úÇдëÇб³ ±æº´¿ø ¼Ò¾Æ°ú
ÀÌ´ë¿ë ( Yi Dae-Yong ) 
°¡ÃµÀÇ°úÇдëÇб³ ±æº´¿ø ¼Ò¾Æû¼Ò³â°úÇб³½Ç

Abstract

¸ñ Àû: ¼Ò¾Æ¿¡¼­ ½Äµµ¿°Àº ¼ºÀΰú ´Þ¸® ³ªÀ̺°·Î ´Ù¾çÇÏ°í, ºñƯÀÌÀûÀÎ Áõ»óÀ̳ª ¡Èĸ¦ º¸ÀδÙ. ¶ÇÇÑ ½Äµµ¿°À» Áø´ÜÇϱâ À§ÇÑ »óºÎ À§Àå°ü ³»½Ã°æ°ú Á¶Á÷ »ý°ËÀ» ½ÃÇàÇÏ´Â °Íµµ ½±Áö ¾Ê´Ù. ÀÌ¿¡ º» ¿¬±¸¿¡¼­´Â ¼Ò¾Æ¿¡¼­ ½Äµµ¿°ÀÇ À¯º´·ü°ú Á¶Á÷ °Ë»çÀÇ Çʿ伺 ¹× À§Çè ÀÎÀÚ¿¡ ´ëÇØ ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

¹æ ¹ý: 2006³â 1¿ùºÎÅÍ 2007³â 12¿ù±îÁö °¡ÃµÀÇ´ë ±æº´¿ø ¼Ò¾Æ°ú¿¡ ³»¿øÇÏ¿© ±Þ¸¸¼º »óº¹ºÎ º¹ÅëÀ» º¸ÀΠȯÀÚµé 266¸íÀ» ´ë»óÀ¸·Î ¹®Áø ¹× ½Åü °Ë»ç, »óºÎ À§Àå°ü ³»½Ã°æ°ú ÇÔ²² ½Äµµ ¹× À§ Á¶Á÷ »ý°ËÀ» ½ÃÇàÇÏ¿´´Ù. ½Äµµ¿°ÀÇ Áø´ÜÀº Á¶Á÷ °Ë»ç·Î È®Áø ÇÏ¿´À¸¸ç, H. pylori °¨¿° ¿©ºÎ´Â CLO °Ë»ç, H&E ¿°»ö°ú Giemsa ¿°»ö ȤÀº ¿ä¼ÒÈ£±â°Ë»ç·Î È®ÀÎÇÏ¿´´Ù. ½Äµµ¿°°ú °ü·ÃµÈ À§ÇèÀÎÀÚ ¹× ³»½Ã°æ ¼Ò°ß°ú Á¶Á÷ÇÐÀû ¼Ò°ßÀÇ °ü·Ã¼ºÀ» ºñ±³ ºÐ¼®ÇÏ¿´´Ù.

°á °ú: »óºÎ ³»½Ã°æ°ú Á¶Á÷ »ý°ËÀ» ½ÃÇà ȯÀÚ 266¸í Áß Á¶Á÷ÇÐÀû ½Äµµ¿° ȯÀÚ´Â Àüü 266¸í Áß 53¸í(19.9%)À̾úÀ¸¸ç, ³²ÀÚ 18¸í(34.0%), ¿©ÀÚ 35¸í(66.0%)À¸·Î Æò±Õ ³ªÀÌ´Â 11.6¡¾0.87¼¼¿´´Ù. ³»½Ã°æ ¼Ò°ßÀÇ ¹Î°¨µµ´Â 41.5%, ƯÀ̵µ´Â 77.0%, ¾ç¼º ¿¹Ãøµµ 31.0%¿´´Ù. Á¶Á÷ÇÐÀû ½Äµµ¿° ȯÀÚ Áß ¿ª·ù¼º ½Äµµ¿°Àº 50¸í, È£»ê±¸¼º ½Äµµ¿°Àº 2¸í, ĵµð´Ù °¨¿°Áõ¿¡ ÀÇÇÑ ½Äµµ¿°Àº 1¸íÀ̾ú´Ù. ¸ðµç ¿¬·É¿¡¼­ º¹ÅëÀÌ °¡Àå ÈçÇÑ Áõ»óÀ¸·Î ³ªÅ¸³µÀ¸¸ç, 8¼¼ ÀÌÇÏ È¯¾Æµé¿¡¼­ ±¸Åä°¡ ÀÇ¹Ì ÀÖ°Ô ¸¹¾Ò´Ù(p£¼0.05). º½¿¡ Á»´õ ¸¹ÀÌ ³»¿øÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µÀ¸¸ç(OR 2.5, 95% CI 1.2544 to 4.8286), H. pylori °¨¿°±º¿¡¼­ ½Äµµ¿°ÀÇ °¡´É¼ºÀÌ ÀÇ¹Ì ÀÖ°Ô ³ô°Ô ³ªÅ¸³µ´Ù (OR 2.5, 95% CI 1.1598 to 4.2798).

°á ·Ð: »óºÎ À§Àå°ü Áõ»óÀÌ Àִ ȯÀÚ¿¡¼­ »óºÎ À§Àå°ü ³»½Ã°æ °Ë»ç¸¦ ½ÃÇàÇÒ ¶§, ƯÈ÷ ÇÐ·É Àü±â ȯÀÚ¿¡¼­ ±¸Å並 µ¿¹ÝÇÑ À§Àå°ü Áõ»óÀÌ Àְųª, º½¿¡ ³»¿ø½Ã, H. pylori °¨¿°ÀÌ ÀÖÀ» °æ¿ì ½Äµµ¿°ÀÇ °¡´É¼ºÀÌ ´õ¿í ³ôÀ¸¹Ç·Î ½Äµµ Á¶Á÷ »ý°ËÀ» °í·ÁÇØ¾ß ÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù.

Purpose: Children with esophagitis express a variety of nonspecific symptoms and signs depending on their age, and diagnosis is limited because gastrointestinal endoscopy (GFS) and biopsy are difficult to perform. The aim of this study was to examine the prevalence of esophagitis in children with upper abdominal pain, to determine the necessity of esophageal biopsy, and to evaluate the associated risk factors.

Methods: We reviewed 266 pediatric patients with upper abdominal pain who underwent history-taking, physical examination, and GFS with esophageal and gastric biopsies between January 2006 and December 2007. Esophagitis was confirmed on biopsy. We analyzed the risk factors for histologic esophagitis and the necessity of esophageal biopsy.

Results: The prevalence of esophagitis was 19.9% (53/266 patients). The sensitivity and specificity of endoscopic diagnosis were 41.5% and 77%. Of 53 patients with histologic esophagitis, reflux esophagitis was seen in 50 patients, eosinophilic esophagitis was seen in 2 patients, and esophageal candidiasis was seen in 1 patient. Vomiting was a significant factor in patients under 8 yr of age (p£¼0.05). H. pylori infection was documented in 41.5% of patients with histologic esophagitis, compared with 58.5% of patients not infected with H. pylori (p£¼0.05). The possibility of histologic esophagitis was higher in patients with H. pylori infection (OR 2.5, 95% CI 1.2544 to 4.8286) and in those who visited in the spring (OR 2.5, 95% CI 1.2544 to 4.8286).

Conclusion: We believe esophageal tissue biopsy should be performed in pediatric patients with upper gastrointestinal symptoms who are undergoing GFS and stomach tissue biopsy, especially preschoolers and H. pylori-infected children in the spring.

Å°¿öµå

sophagitis;Children;Abdominal pain

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS